Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis
批准号:
10418725
负责人:
C. Henrique Serezani
金额:
$55.66万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-15 至 2023-06-30
关键词:
Academic Medical CentersAcute Lung InjuryAnimalsAnti-Inflammatory AgentsApoptosisBindingBloodBlood VesselsButyratesCellsCessation of lifeComplexDataDevelopmentDiseaseEnsureEnvironmentEnzymesEquilibriumEventExhalationExhibitsFatty AcidsGene ExpressionGenerationsGeneticGenetic TranscriptionGlycolysisGoalsHomeostasisHost DefenseHumanHydroxyl RadicalIL18 geneIL1R1 geneImmuneImmune responseImmunologyIndividualInfiltrationInflammasomeInflammationInflammation MediatorsInflammatoryInflammatory ResponseIntensive Care UnitsInterleukin-1 betaLeadLeukocytesLipidsLungMaintenanceMediatingMedicineMetabolicMetabolic PathwayMicroRNAsMolecularMolecular TargetMorbidity - disease rateMusMyelogenousMyeloid CellsNonesterified Fatty AcidsNosocomial InfectionsNucleotidesOperative Surgical ProceduresOrganOrgan failureOutcomePTEN genePathway interactionsPersonsPhagocytesPhosphorylationPlant RootsPredispositionProductionProtein phosphatasePublishingPulmonary InflammationRNA StabilityRespiratory FailureRoleSepsisSeriesSerumSeverity of illnessShapesSignal TransductionSiteSyndromeSystemic Inflammatory Response SyndromeSystemic infectionTechniquesTestingTherapeuticTherapeutic InterventionTissuesTraumaUntranslated RNAWorkantimicrobialarmcytokineexperienceexperimental studyfatty acid metabolismfatty acid oxidationgain of functionimprovedinhibitorinsightlung injurymacrophagemetabolic profilemortalityneutrophilnovelnovel therapeuticsorgan injurypleiotropismpolymicrobial sepsispre-clinicalpreventprogramsreceptorseptictargeted treatmenttissue injury
中文摘要
简介:
英文摘要
SUMMARY:
Sepsis is a significant cause of morbidity and mortality. Severe sepsis complicated with multiple organ injury and
acute lung injury (ALI)-induced respiratory failure frequently serves as a direct reason of death. During sepsis,
unrestrained stimulation of leukocytes and structural cells can induce Systemic Inflammatory Response
Syndrome (SIRS) resulting in tissue injury and susceptibility to nosocomial infection. Unfortunately, as no
effective medicine is available to treat the developing SIRS/organ injury in these individuals, there is a strong
need to further dissect the complex events that lead to the initiation and progression of SIRS. The long-term goal
of this project is to identify endogenous inhibitors of phagocyte function that could decrease different arms of the
inflammatory response while restoring antimicrobial effector functions. This renewal is built upon published and
preliminary data generated while investigating the role of the phosphatase and tensin homolog PTEN in
microRNA-mediated MyD88 degradation and the generation of SIRS during sepsis. We found that PTEN
deficiency enhances mortality in septic mice; that miR21 (a microRNA that targets PTEN) is a homeostatic
regulator of macrophage inflammatory response and that preventing excessive glycolysis decreases SIRS
development, ALI formation and improves animal survival. Our preliminary data suggest that in addition to
controlling transcriptional programs, PTEN also directly inhibits the inflammasome (intracellular inflammatory
platforms)-dependent release of potent inflammatory mediators. PTEN also stimulates fatty acid oxidation (FAO),
which inhibits inflammation. Furthermore, we also found that miR21 inhibits the expression of genes involved in
FAO, which correlates with decreased animal survival, increased lung inflammation and mortality. From these
findings, we formulated our central hypothesis that during sepsis, myeloid-specific signaling along the
miR21/PTEN/FAO axis becomes dysregulated and drives lung injury and lethality during sepsis. This hypothesis
will be examined by testing the 1) role of PTEN in inflammasome activation in phagocytes in sepsis and 2)
Determine the role of the miR21/PTEN axis in lung injury and mortality during sepsis. We will employ a series of
state-of-the-art techniques, along with epistatic and gain of function approaches to unveil new signaling programs
that ultimately might influence ALI and mortality during systemic infections. The combination of the PI’s
experience in sepsis, lung immunology and inflammation, the assembled team of collaborators, and the
environment at Vanderbilt University Medical Center ensure that this work will be accomplished. The
identification of specific components and their modes of action in maintenance of sepsis may identify targets for
therapeutic intervention resulting in improved immune responsiveness in settings of host vulnerability, and may
suggest strategies to dampen the immune response in settings of exaggerated inflammation.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
SOCS-1 inhibition of type I interferon restrains Staphylococcus aureus skin host defense.
I型干扰素抑制SOCS-1抑制金黄色葡萄球菌皮肤宿主防御。
DOI:
10.1371/journal.ppat.1009387
发表时间:
2021-03
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Klopfenstein N, Brandt SL, Castellanos S, Gunzer M, Blackman A, Serezani CH]
通讯作者:
Serezani CH
DOI:
10.1038/ncomms10760
发表时间:
2016-02-23
期刊:
Nature communications
影响因子:
16.6
作者:
[Zoccal KF, Sorgi CA, Hori JI, Paula-Silva FW, Arantes EC, Serezani CH, Zamboni DS, Faccioli LH]
通讯作者:
Faccioli LH
DOI:
10.1371/journal.pone.0115855
发表时间:
2015
期刊:
PloS one
影响因子:
3.7
作者:
[Wang Z, Brandt S, Medeiros A, Wang S, Wu H, Dent A, Serezani CH]
通讯作者:
Serezani CH
Innate Immunity to Staphylococcus aureus: Evolving Paradigms in Soft Tissue and Invasive Infections.
DOI:
10.4049/jimmunol.1701574
发表时间:
2018-06-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Brandt SL, Putnam NE, Cassat JE, Serezani CH]
通讯作者:
Serezani CH
DOI:
10.1038/srep32092
发表时间:
2016-08-24
期刊:
Scientific reports
影响因子:
4.6
作者:
[Ishizuka EK, Filgueiras LR, Rios FJ, Serezani CH, Jancar S]
通讯作者:
Jancar S
共 12 条
Prostaglandin E2 Actions and Enhanced Susceptibility to Skin Infection in Diabetic Mice
-
批准号:9980677
-
项目类别:
-
资助金额:$62.03万
-
财政年份:2020
-
负责人:C. Henrique Serezani
-
依托单位:
Prostaglandin E2 Actions and Enhanced Susceptibility to Skin Infection in Diabetic Mice
-
批准号:10337275
-
项目类别:
-
资助金额:$50.72万
-
财政年份:2020
-
负责人:C. Henrique Serezani
-
依托单位:
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis
-
批准号:8762864
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2014
-
负责人:C. Henrique Serezani
-
依托单位:
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis
-
批准号:10005956
-
项目类别:
-
资助金额:$57.07万
-
财政年份:2014
-
负责人:C. Henrique Serezani
-
依托单位:
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis
-
批准号:9332397
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2014
-
负责人:C. Henrique Serezani
-
依托单位:
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis
-
批准号:9088490
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2014
-
负责人:C. Henrique Serezani
-
依托单位:
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis
-
批准号:10201714
-
项目类别:
-
资助金额:$57.07万
-
财政年份:2014
-
负责人:C. Henrique Serezani
-
依托单位:
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptors
-
批准号:8646977
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2010
-
负责人:C. Henrique Serezani
-
依托单位:
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptors
-
批准号:8458283
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:C. Henrique Serezani
-
依托单位:
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptors
-
批准号:7953238
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2010
-
负责人:C. Henrique Serezani
-
依托单位:
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptors
-
批准号:8529599
-
项目类别:
-
资助金额:$23.17万
-
财政年份:2010
-
负责人:C. Henrique Serezani
-
依托单位:
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptors
-
批准号:8132358
-
项目类别:
-
资助金额:$12.24万
-
财政年份:2010
-
负责人:C. Henrique Serezani
-
依托单位:
海外基金